This revised proposal is submitted in response to PA-04-119 Biodefense and Emerging Infectious Disease Research Opportunities. The experiments proposed address the mechanism(s) by which Ebola viruses (EBOV) evade the host cell interferon (IFN)alpha/beta response, a critical component of host innate immunity to viruses. EBOV are NIAID category A pathogens which cause highly lethal viral hemorrhagic fever. This proposal builds on previous studies performed by the PI and his collaborators which demonstrated that the Ebola virus VP35 protein acts as an """"""""IFN-antagonist;"""""""" that is, VP35 is able to prevent in cells establishment of an IFNalpha/beta-induced antiviral state by blocking a critical step in the induction of the host IFN response, the activation of interferon regulatory factor 3 (IRF-3), (Basler et al. PNAS 97: 12289-12294, 2000; Easier et al. J. Virol. 77:7945-56, 2003). A recent study finds that VP35 blocks multiple IFNalpha/beta-inducing pathways including a pathway activated by RIG-I, a putative RNA helicase which is reportedly critical for the virus and dsRNA-induced production of IFNalpha/beta. This proposal expands on these earlier studies and seeks to define the mechanism(s) by which VP35 blocks signaling pathways that lead to the production of IFNalpha/beta and to determine the importance of this """"""""IFN-antagonist"""""""" function for Ebola virus replication.
The specific aims of the proposal are to: 1. Analyze the mechanism by which VP35 inhibits signaling to IRF-3 by the cellular RNA helicase RIG-I. 2. Define the specific IRF-3 phosphorylation events inhibited by VP35 and assess the impact of VP35 on the IRF3 kinases IKKepsilon and TBK-1. 3. Determine how participation by VP35, a multifunctional protein required for viral RNA synthesis and assembly, in viral polymerase and nucleocapsid complexes affects its """"""""interferon-antagonist"""""""" function and define regions of VP35 required for interferon-antagonist function. 4. Generate VP35 mutant Ebola viruses and characterize their ability to antagonize the host IFN-response. This last aim will seek to correlate the mechanistic data obtained in Aims 1 and 2 with observations made in EBOV-infected cells and determine the importance of VP35 """"""""IFN-antagonist"""""""" activity for virus replication by generating and characterizing mutant, recombinant EBOV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI059536-04
Application #
7404459
Study Section
Virology - A Study Section (VIRA)
Program Officer
Repik, Patricia M
Project Start
2005-07-01
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$345,672
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Yen, Benjamin C; Basler, Christopher F (2016) Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection. J Virol 90:5108-5118
Edwards, Megan R; Liu, Gai; Mire, Chad E et al. (2016) Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. Cell Rep 14:1632-1640
Basler, Christopher F (2015) Innate immune evasion by filoviruses. Virology 479-480:122-30
Luthra, Priya; Jordan, David S; Leung, Daisy W et al. (2015) Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis. J Virol 89:5148-53
Messaoudi, Ilhem; Basler, Christopher F (2015) Immunological features underlying viral hemorrhagic fevers. Curr Opin Immunol 36:38-46
Messaoudi, Ilhem; Amarasinghe, Gaya K; Basler, Christopher F (2015) Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol 13:663-76
Feagins, Alicia R; Basler, Christopher F (2015) Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells. J Infect Dis 212 Suppl 2:S219-25
Edwards, Megan R; Basler, Christopher F (2015) Marburg Virus VP24 Protein Relieves Suppression of the NF-?B Pathway Through Interaction With Kelch-like ECH-Associated Protein 1. J Infect Dis 212 Suppl 2:S154-9
Leung, Daisy W; Borek, Dominika; Luthra, Priya et al. (2015) An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell Rep 11:376-89
Teixeira, Avelino; Yen, Benjamin; Gusella, Gabriele Luca et al. (2015) Prothymosin ? variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction. J Infect Dis 211:1467-75

Showing the most recent 10 out of 57 publications